Press coverage about Vascular Solutions (NASDAQ:VASC) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vascular Solutions earned a media sentiment score of 0.03 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 45.0768088184835 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Self-Expanding Peripheral Vascular Stents Market Analysis and Forecast up to 2024 (mynewsdesk.com)
- Dupont Hospital Appoints Suter CEO (insideindianabusiness.com)
- Vascular Access Systems Market Global Market Opportunity Assessment Study 2026 (reports.pr-inside.com)
Vascular Solutions (NASDAQ:VASC) opened at $56.00 on Wednesday. Vascular Solutions has a one year low of $25.06 and a one year high of $57.15.
Vascular Solutions Company Profile
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
What are top analysts saying about Vascular Solutions Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Vascular Solutions Inc. and related companies.